Dr. Randa Tao
Claim this profileHuntsman Cancer Institute/University of Utah
Studies Esophageal Cancer
Studies Esophageal Adenocarcinoma
4 reported clinical trials
11 drugs studied
Area of expertise
1Esophageal Cancer
Stage IV
HER2 negative
Stage I
2Esophageal Adenocarcinoma
Stage IV
HER2 negative
Stage I
Affiliated Hospitals
Clinical Trials Randa Tao is currently running
Chemotherapy + Radiotherapy
for Esophageal and Gastric Cancer
This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy x-rays, gamma rays, or protons to kill tumor cells and shrink tumors. Drugs used in usual chemotherapy, such as leucovorin, 5-fluorouracil, oxaliplatin, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Adding radiotherapy to the usual chemotherapy may work better compared to the usual chemotherapy alone in treating patients with esophageal and gastric cancer.
Recruiting2 awards Phase 320 criteria
Hypoxia-Guided Radiation
for Esophageal Cancer
This is a Phase I trial evaluating the safety of personalized radiation therapy based on levels of hypoxia identified on FMISO-PET and MRI. All patients will receive a baseline FMISO positron emission tomography (PET) and MRI to identify levels of hypoxia. Patients with tumor hypoxia will receive a higher dose of radiation therapy. Subjects who do not have hypoxic tumors will be treated with the standard-of-care radiation regimen. After fraction 10 of radiation therapy, an additional MRI will be performed. If this interim MRI demonstrates little or no response (as defined in Section 6), an optional boost radiation dose can be administered. Trial enrollment will be conducted in two parts. In Part 1, eight patients will be enrolled. After all eight patients have completed the 30 day dose-limiting toxicity (DLT) period, enrollment will be placed on hold and safety will be evaluated. During the interim analysis, one additional patient will be allowed to be enrolled in the trial. If the trial meets stopping rules as described in Section 11.3, the trial will be re-evaluated by the Data and Safety Monitoring Committee (DSMC) and the Principal Investigator. However, if the rate of DLTs remains below the unacceptable toxicity rate, enrollment will open to the enrollment of eight more patients.
Recruiting1 award Phase 17 criteria
More about Randa Tao
Clinical Trial Related4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Randa Tao has experience with
- Radiation Therapy
- FMISO PET CT
- Fluorouracil
- Capecitabine
- Oxaliplatin
- Leucovorin
Breakdown of trials Randa Tao has run
Esophageal Cancer
Esophageal Adenocarcinoma
Stomach Cancer
Esophageal cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Randa Tao specialize in?
Randa Tao focuses on Esophageal Cancer and Esophageal Adenocarcinoma. In particular, much of their work with Esophageal Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Randa Tao currently recruiting for clinical trials?
Yes, Randa Tao is currently recruiting for 3 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Randa Tao has studied deeply?
Yes, Randa Tao has studied treatments such as Radiation Therapy, FMISO PET CT, Fluorouracil.
What is the best way to schedule an appointment with Randa Tao?
Apply for one of the trials that Randa Tao is conducting.
What is the office address of Randa Tao?
The office of Randa Tao is located at: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah 84112 United States. This is the address for their practice at the Huntsman Cancer Institute/University of Utah.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.